As people with cystic fibrosis live longer, there is a growing demand for physicians who are trained to address the unique medical needs of adults with CF and a need for greater participation from adult care programs in the clinical research enterprise.
Site Search
Since 2011, the Foundation has awarded $2.5 million across 35 different projects to improve cystic fibrosis newborn screening across the country.
Funding will support a Phase 2b trial of phage therapy for chronic Pseudomonas aeruginosa lung infections.
Postdoctoral research fellowship awards are offered to MDs, PhDs, and MD/PhDs who are interested in conducting basic research related to cystic fibrosis.
In 1955, the Cystic Fibrosis Foundation was founded by a group of concerned parents who wanted to raise awareness of CF. The strength of the CF community has driven forward incredible advancements in research and care. It’s important to remember that one voice can make all the difference.
This program supports research that will accelerate the discovery and development of therapies to restore cystic fibrosis transmembrane conductance regulator (CFTR) function in all patients with cystic fibrosis.
Research grants are intended to encourage the development of new information that contributes to the understanding of the basic etiology and pathogenesis of cystic fibrosis.
Pilot and feasibility awards are intended to support basic science research studies focused on developing and testing new hypotheses in areas relevant to cystic fibrosis.
This year’s program marked the largest in-person advocacy event in the Foundation’s history.
The Cystic Fibrosis Foundation regularly assesses its key research priorities to ensure we are on track to accomplish our mission to cure CF and to provide people with CF the opportunity to lead long lives. Applicants are encouraged to align submissions to these priorities to maximize their potential for being funded.